HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Bi Selected Research

hederagenin

3/2022Design, synthesis, and tumor drug resistance reversal activity of novel hederagenin derivatives modified by nitrogen-containing heterocycles.
2/2021Design, synthesis, and biological evaluation of hederagenin derivatives with improved aqueous solubility and tumor resistance reversal activity.
12/2017Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Bi Research Topics

Disease

16Neoplasms (Cancer)
03/2022 - 03/2007
3Lung Neoplasms (Lung Cancer)
07/2018 - 01/2016
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2021 - 11/2019
2Breast Neoplasms (Breast Cancer)
02/2021 - 11/2017
2Inflammation (Inflammations)
01/2021 - 11/2018
2Neoplasm Metastasis (Metastasis)
07/2018 - 01/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2018 - 04/2016
2Experimental Melanoma
11/2013 - 07/2012
1Bacterial Infections (Bacterial Infection)
10/2021
1Infections
01/2021
1Staphylococcal Infections
01/2021
1Adenocarcinoma of Lung
01/2020
1Leukemia
01/2020
1Colonic Neoplasms (Colon Cancer)
11/2018
1Colitis
11/2018
1Colorectal Neoplasms (Colorectal Cancer)
11/2018
1Abdominal Pain (Pain, Abdominal)
11/2018
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2010

Drug/Important Bio-Agent (IBA)

4Paclitaxel (Taxol)FDA LinkGeneric
03/2022 - 01/2018
4Fluorouracil (Carac)FDA LinkGeneric
11/2018 - 03/2007
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2022 - 01/2018
3hederageninIBA
03/2022 - 12/2017
3Fusidic Acid (Fucithalmic)IBA
01/2021 - 01/2019
3Proteins (Proteins, Gene)FDA Link
11/2017 - 01/2015
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013 - 03/2007
2NitrogenIBA
03/2022 - 02/2021
2Biological ProductsIBA
02/2021 - 07/2018
2Pharmaceutical PreparationsIBA
01/2020 - 01/2016
1Anti-Bacterial Agents (Antibiotics)IBA
10/2021
1Rhodamine 123IBA
02/2021
1Antimalarials (Antimalarial Agents)IBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1CoagulaseIBA
01/2021
1TriterpenesIBA
01/2021
1CateninsIBA
01/2020
1Cyclin D1IBA
01/2020
1fosbretabulin (combretastatin A4)IBA
02/2019
1Antineoplastic Agents (Antineoplastics)IBA
02/2019
1CytokinesIBA
11/2018
1Long Noncoding RNAIBA
07/2018
1Insulin-Like PeptidesIBA
07/2018
1Competitive Endogenous RNAIBA
07/2018
1Cytotoxins (Cytolysins)IBA
12/2017
1PolyaminesIBA
12/2017
1Canertinib (CI 1033)IBA
11/2017
1Sirolimus (Rapamycin)FDA Link
11/2017
1Gefitinib (Iressa)FDA Link
11/2017
1Interleukin-22 (IL-22)IBA
04/2016
1DammaranesIBA
10/2010
1AcidsIBA
03/2007
1Betulinic AcidIBA
03/2007
1EstersIBA
03/2007

Therapy/Procedure

3Therapeutics
07/2019 - 11/2018
1Drug Therapy (Chemotherapy)
04/2016